Tag:
Kite Pharma
Latest Headlines
Latest Headlines
Cancer vax developer Kite lands $15M
LA-based Kite Pharma, a fledgling biotech that has set out to develop new cancer vaccine therapies, has raised $15 million in Series A venture cash. The company will use the funding to support
Fledgling cancer vax biotech raises $15M in Series A
LA-based Kite Pharma, a fledgling biotech that has set out to develop new cancer vaccine therapies, has raised $15 million in Series A venture cash. David Bonderman, a founding partner of TPG Capital
